The product is expected to be returned for analysis; however, it has not yet been received.Upon the return of the product a supplemental report will be sent with the investigation results.The lot number was not provided; therefore, a review of the manufacturing records could not be completed.
|
The unknown yellowish material was sent to chemistry for ir spectrum and energy dispersive spectroscopy (eds) tests.The ir spectrum did not show distinct (peak) spectrum signature, therefore it was unable to match to a suitable material.Results from eds indicated the presence of the following elements: carbon, oxygen, sodium and chlorine.An investigation has been initiated to consider any potential manufacturing factors that may have contributed to this complaint and implement any necessary corrective actions.
|
One swan ganz catheter with attached monoject 1.5 cc limited volume syringe was returned for evaluation.Customer report of balloon deflation issue could not be confirmed during the analysis, however, contamination was found inside the gate valve.The balloon inflated clear, concentric and remained inflated for 5 minutes without leakage.The balloon deflated within 2 seconds without a syringe attached.The specification for balloon deflation without a syringe attached is 4 seconds.An unknown yellowish material, approximately 1 mm x 1 mm in size, was observed inside the gate valve.The material was not detached during evaluation.The unknown material was removed and sent to chemistry for analysis.All through lumens were patent without any leakage or occlusion.No visible damage was observed from the catheter body or returned syringe.Balloon inflation testing was performed using returned syringe with 1.5 cc air by holding the balloon under water for 5 minutes.Visual examination was performed under microscope at 10x magnification and with the unaided eyes.The lot number was obtained from the label of the returned device.A device history record review was completed and documented that device met all specifications upon distribution.A supplemental report will be sent with the chemistry investigation results.Invasive procedures involve some patient risks.Although serious complications are relatively uncommon, the physician is advised, before deciding to insert or use the catheter, to consider the potential benefits in relation to the possible complications.The techniques for insertion, methods of using the catheter to obtain patient data information, and the occurrence of complications is well described in the literature.With any hemodynamic monitoring, patient parameters can change quickly and dramatically.Patient parameters should correlate with the patient¿s clinical manifestations.In this case it is unknown whether any user or procedural factors may have contributed to the stated event.Complaint histories for all reported events are reviewed against trending control limits on a monthly basis, and any excursions above the control limits are assessed and documented as part of this monthly review.
|